Vitae Pharmaceuticals
A clinical-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds.
Launch date
Employees
Market cap
-
Enterprise valuation
$639m (Public information from Sep 2016)
Upper Merion Township Pennsylvania (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$15.0m | Series B | ||
$34.0m | Series B | ||
$15.0m | Series C | ||
$15.0m | Series D | ||
| N/A | $15.0m | Late VC | |
| N/A | $65.0m Valuation: $198m | IPO | |
$639m Valuation: $639m | Acquisition | ||
| Total Funding | $94.0m | ||
Related Content
Recent News about Vitae Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.